Pembrolizumab available for more people with Hodgkin lymphoma
NICE has expanded access to pembrolizumab on the NHS.
News
New treatments and drug approvals
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
BSH updates guidelines on T-cell lymphomas and NK-cell lymphomas
New guidelines give clear treatment recommendations for people with T-cell and NK-cell lymphomas
New treatment approval for relapsed or refractory DLBCL
The UK’s Medicines & Healthcare products Regulatory Agency (MHRA) has approved tafasitamab, combined with lenalidomide, for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who can’t have a stem cell transplant.
Ibrutinib monotherapy available on the NHS in Scotland for relapsed or refractory WM
Ibrutinib monotherapy has been approved for NHS in Scotland for adults with Waldenström’s macroglobulinaemia who have had at least one previous course of treatment.
New combination treatment tested for primary CNS lymphoma
The TIER trial has found that a new combination of chemotherapy and antibody therapy can produce meaningful responses in people with relapsed or refractory CNS lymphoma.
New treatment for skin lymphoma available on the NHS in England and Wales
NICE has recommended mogamulizumab for the treatment of relapsed or refractory mycosis fungoides or Sézary syndrome
Pembrolizumab available for more people with Hodgkin lymphoma in Scotland
The Scottish Medicines Consortium has expanded access to pembrolizumab on the NHS in Scotland.
UK approves monoclonal antibody Ronapreve to treat COVID-19
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved monoclonal antibody treatment Ronapreve to prevent and fight COVID-19 in the UK.
CAR T-cell therapy available for mantle cell lymphoma in Scotland
KTE-X19 has been approved for NHS use in Scotland for people with relapsed or refractory mantle cell lymphoma.
Chemotherapy gel for T-cell skin lymphoma approved for NHS use in England and Wales
NICE has approved chlormethine gel for NHS use for adults with mycosis fungoides.